- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06179927
Group Intervention on Theory of Mind in Children With Autism Spectrum Disorder.
Enhancing Theory of Mind Skills in Children With Autism Spectrum Disorder.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Giovanni Pioggia
- Phone Number: +393203390892
- Email: giovanni.pioggia@irib.cnr.it
Study Contact Backup
- Name: Germana Doria
- Phone Number: +393465142289
- Email: germana.doria@irib.cnr.it
Study Locations
-
-
-
Messina, Italy, 98164
- Recruiting
- Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR)
-
Contact:
- Flavia Marino
- Phone Number: +393395798263
- Email: flavia.marino@irib.cnr.it
-
Contact:
- Giovanni Pioggia
- Phone Number: +393203390892
- Email: giovanni.pioggia@irib.cnr.it
-
Principal Investigator:
- Flavia Marino
-
Sub-Investigator:
- Giovanni Pioggia
-
Sub-Investigator:
- Paola Chilà
-
Sub-Investigator:
- Roberta Minutoli
-
Sub-Investigator:
- Noemi Vetrano
-
Sub-Investigator:
- Chiara Failla
-
Sub-Investigator:
- Germana Doria
-
Sub-Investigator:
- Ileana Scarcella
-
Principal Investigator:
- Alberto Scandurra
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Proven diagnosis of autism
- QS ≥ 75 assessed by administration of the GRIFFITHS scales
- Passing the emotional recognition test of the NEPSY II battery
Exclusion Criteria:
- presence of other medical disorders
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: QT robot treatment
Twenty children from the experimental group will undergo the treatment using QT Robot and the tablet.
|
The subjects will undergo a pre-intervention assessment phase that will consist of administering the Theory Of Mind (TOM) test found in the NEuroPSYcology second edition (NEPSY) battery, part A; the same test will be re-submitted at the end of the intervention.
Having ascertained the presence of the inclusion criteria and following randomization of the sample, the Experimental Group constituted of 20 children, will be administered the research task, which involves 12 sessions, one per week lasting 45 minutes.
the experimental group will view 12 social scenes made via tablet.
In the scenario, the depictions will be presented in color.
They, guided by QT Robot's narrator voice, will have to choose from two or three alternatives the one that represents the appropriate mental state by selecting it on the tablet.
Consequently, audio visual feedback will be provided, via the robot, to return information to the subject about the accuracy of the response.
|
|
Experimental: Traditional treatment
Twenty children belonging to the control group will be subjected to the same training but in a traditional way, that is, by presenting image stimuli in a paper format.
|
The subjects will undergo a pre-intervention assessment phase that will consist of administering the Theory Of Mind (TOM) test found in the NEuroPSYcology second edition (NEPSY) battery, part A; the same test will be re-submitted at the end of the intervention.
Having ascertained the presence of the inclusion criteria and following randomization of the sample, the control group constituted of 20 children, will be administered the research task, which involves 12 sessions, one per week lasting 45 minutes.
the experimental group will view 12 social scenes on paper.
They, guided by the narrator's voice of the operator will have to choose from two or three alternatives the one that represents the appropriate mental state by indicating it on the paper.
Consequently, feedback will be provided by the operator to return information to the subject on the accuracy of the response.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
NEuroPSYcology second edition (NEPSY-II) evaluations
Time Frame: The tests will be scheduled pre intervention (T0), at 6 months (T1) and at the study conclusion, about 1 year (T2).The test needs about 120-180 minutes.
|
NEuroPSYcology second edition (NEPSY-II) is the most internationally known battery for assessing neuropsychological development in developmental age. Each NEPSY-II test provides raw scores that must be converted into scalar scores (min 1 - max 19) or percentile scores (min <2% - max >75%) according to the conversion tables in the manual. For each sub-scale higher scores correspond to better performance. NESPY's Theory of Mind (ToM) sub test, section A is used in this protocol. Assesses the ability to decode and interpret others' intentions and life points and understand how they influence behavior. the test will be given to children pre- and post-intervention. The ToM test is divided into verbal: the child is read scenarios or shown figures and asked questions that require understanding of the other's point of view; nonverbal: the child is asked to choose the emotional expression appropriate to the mood of a character depicted in certain contexts. |
The tests will be scheduled pre intervention (T0), at 6 months (T1) and at the study conclusion, about 1 year (T2).The test needs about 120-180 minutes.
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Flavia Marino, Istituto per la Ricerca e l'Innovazione Biomedica
Publications and helpful links
General Publications
- Lecce S & Bianco F. Mettiti nei miei panni, Erickson 2018
- Begeer S. et al. Effects and Moderators of a Short Theory of Mind Intervention for Children with Autism Spectrum Disorder: A Randomized Controlled Trial, 2015
- Helen Tager-Flusberg, Evaluating the Theory-of-Mind Hypothesis of Autism, 2007
- Uta Frith, Autism and Theory of mind in everyday life, 2018
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CNR-IRIB-PRO-2023-008
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Istituto Clinico HumanitasRecruitingAutism | Autism Spectrum Disorder (ASD) | Autism DisorderItaly
-
The Children's Hospital of Zhejiang University...Not yet recruitingAutism | Autism Spectrum Disorder (ASD)China
-
Poznan University of Physical EducationCompletedAutism | Autism Spectrum Disorder (ASD)Poland
-
Greater Atlanta Integrative PediatricsRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Adia Med of Winter Park LLCRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Poznan University of Physical EducationNational Science Centre, PolandCompletedAutism Spectrum Disorder | ASD | Autism Spectrum Disorder High-Functioning | Autism SpectrumPoland
-
Stanford UniversityJohn and Marcia Goldman FoundationNot yet recruitingAutism | Autism Spectrum Disorder (ASD)United States
-
Blinklab LimitedRecruitingAutism Spectrum Disorder | Autism | Neurodevelopmental Conditions | Autism Spectrum Disorder (ASD)United States
-
National Cheng-Kung University HospitalCompletedAutism Spectrum Disorder (ASD) | Autism Spectrum Disorder High-FunctioningTaiwan
-
University of California, Los AngelesUniversity of WashingtonRecruitingAutism Spectrum Disorder (ASD)United States
Clinical Trials on QT voice
-
Institute of Hematology & Blood Diseases Hospital...Shanghai Xiniao Biotech Co., Ltd.RecruitingSLE - Systemic Lupus Erythematosus | ANCA Associated Vasculitis (AAV) | IIM- Idiopathic Inflammatory Myopathies | SSc-Systemic Sclerosis | Connective Tissue Disease-Associated Thrombocytopenia | SLE-ITPChina
-
Tianjin Huanhu HospitalNot yet recruitingMultiple Sclerosis | Myasthenia Gravis | Neuromyelitis Optica Spectrum DisordersChina
-
Istituto per la Ricerca e l'Innovazione BiomedicaComune di MessinaNot yet recruitingAutism Spectrum Disorder | AutismItaly
-
Haseki Training and Research HospitalCompleted
-
The Children's Hospital of Zhejiang University...RecruitingAutoimmune Diseases | IgA Nephropathy (IgAN) | ANCA Associated Systemic Vasculitis | Systemic Sclerosis (SSc) | Multi-Drug Resistant Nephrotic Syndrome | Systemic Lupus Erthematosus (SLE)China
-
QT Ultrasound LLCCompletedBreast FibroadenomaUnited States
-
KU LeuvenAgentschap voor Innovatie door Wetenschap en TechnologieCompleted
-
The Second Hospital of Anhui Medical UniversityRecruitingAIHA - Warm Autoimmune Hemolytic Anemia | UCARTChina
-
Hangzhou Qihan Biotech Co., Ltd.RecruitingSystemic Lupus Erythematosus (SLE)China
-
QT Ultrasound LLCCompleted